PMID: 7708669Mar 28, 1995Paper

Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove

Proceedings of the National Academy of Sciences of the United States of America
D H FremontI A Wilson

Abstract

Sequence analysis of peptides naturally presented by major histocompatibility complex (MHC) class I molecules has revealed allele-specific motifs in which the peptide length and the residues observed at certain positions are restricted. Nevertheless, peptides containing the standard motif often fail to bind with high affinity or form physiologically stable complexes. Here we present the crystal structure of a well-characterized antigenic peptide from ovalbumin [OVA-8, ovalbumin-(257-264), SIINFEKL] in complex with the murine MHC class I H-2Kb molecule at 2.5-A resolution. Hydrophobic peptide residues Ile-P2 and Phe-P5 are packed closely together into binding pockets B and C, suggesting that the interplay of peptide anchor (P5) and secondary anchor (P2) residues can couple the preferred sequences at these positions. Comparison with the crystal structures of H-2Kb in complex with peptides VSV-8 (RGYVYQGL) and SEV-9 (FAPGNYPAL), where a Tyr residue is used as the C pocket anchor, reveals that the conserved water molecule that binds into the B pocket and mediates hydrogen bonding from the buried anchor hydroxyl group could not be likewise positioned if the P2 side chain were of significant size. Based on this structural evidence, H...Continue Reading

References

Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M R JacksonP A Peterson
Dec 5, 1992·Journal of Molecular Biology·E A SturaI A Wilson
Mar 1, 1989·The Journal of Experimental Medicine·F R Carbone, M J Bevan
Sep 20, 1987·Journal of Molecular Biology·S SheriffJ L Smith
Jun 17, 1986·Biochemistry·A A RashinB Honig
Apr 28, 1968·Journal of Molecular Biology·B W Matthews
Apr 1, 1994·Current Opinion in Immunology·K A HogquistM J Bevan
May 20, 1994·Journal of Molecular Biology·I K McDonald, J M Thornton
Nov 1, 1993·European Journal of Immunology·K A HogquistM J Bevan
Jan 14, 1994·Cell·K A HogquistF R Carbone
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·H C GuoD C Wiley
Jan 1, 1993·Annual Review of Immunology·H G RammenseeO Rötzschke
Jan 1, 1993·Annual Review of Immunology·R N Germain, D H Margulies

❮ Previous
Next ❯

Citations

Jan 1, 1997·Biopolymers·M A Batalia, E J Collins
Jun 27, 1998·Journal of Peptide Science : an Official Publication of the European Peptide Society·P J Fairchild
Feb 2, 1999·Journal of Peptide Science : an Official Publication of the European Peptide Society·A BiancoG Jung
Apr 1, 1998·Protein Science : a Publication of the Protein Society·C A ScottL Teyton
Nov 17, 2010·Journal of Molecular Modeling·Athanassios StavrakoudisVasso Apostolopoulos
Jun 14, 1995·Journal of Immunological Methods·S N KhilkoD H Margulies
Jan 27, 2004·Biochemical and Biophysical Research Communications·Nelson Acosta-RiveroJuan Morales-Grillo
Apr 7, 2004·Journal of Molecular Biology·Paula M Petrone, Angel E Garcia
Dec 31, 2002·Journal of Immunological Methods·Susan E BrophyDavid M Kranz
Sep 6, 2003·Journal of Immunological Methods·Christian R KreherMagdalena Tary-Lehmann
Jun 27, 2002·Journal of Molecular Biology·Vasso ApostolopoulosMagdalena Plebanski
Jun 27, 2002·Journal of Molecular Biology·Vasso ApostolopoulosMagdalena Plebanski
Nov 26, 2002·Journal of Molecular Biology·Olivier Michielin, Martin Karplus
May 4, 2001·Human Immunology·P KangueaneE C Ren
Aug 15, 2002·Human Immunology·Pedro A RecheEllis L Reinherz
Feb 1, 1997·Current Opinion in Immunology·P Cresswell, J C Howard
Feb 1, 1997·Current Opinion in Immunology·E Y Jones
May 14, 1999·Current Opinion in Immunology·S Buus
Dec 23, 1999·Current Opinion in Structural Biology·K Maenaka, E Y Jones
Apr 7, 1998·Nature Biotechnology·V ApostolopoulosI F McKenzie
Mar 26, 2004·Nature Reviews. Immunology·Janko Nikolich-ZugichIlhem Messaoudi
Jun 1, 1997·Nature Structural Biology·A Joachimiak
Jun 1, 1996·The Journal of Experimental Medicine·P Brossart, M J Bevan
Dec 1, 1996·The Journal of Experimental Medicine·S W ReidE Y Jones
Nov 24, 2004·The Journal of Experimental Medicine·Michael J MileyDaved H Fremont
Jul 6, 2000·International Immunology·W S MengI S Haworth
Oct 25, 2000·Protein Science : a Publication of the Protein Society·O Schueler-FurmanH Margalit
Jan 24, 2008·BMC Immunology·John SidneyAlessandro Sette

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.